AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33176232 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-line treatment for mBC
Number of subjects: 21119
Study 36079871 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention based on the Mediterranean diet
Number of subjects: 29
Study 36079871 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 29
Study 33171419 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA)
Number of subjects: 179
Study 33171419 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment (hysterectomy, myomectomy, or UAE)
Number of subjects: 179
Study 35907513 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 500mg by mouth three times a day for 30 to 36 months
Number of subjects: 83
Study 35907513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 34428506 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time reminders activated in rooms
Number of subjects: 111
Study 34428506 — intervention group
Group type: COMPARATOR
Intervention: No real-time reminders activated in rooms
Number of subjects: 111
Study 33011202 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP communication device (SPEAX, Ataia Medical)
Number of subjects: 36
Study 33011202 — intervention group
Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 36
Study 32928570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) associated with Stabilization Exercises (SE)
Number of subjects: 40
Study 32928570 — intervention group
Group type: COMPARATOR
Intervention: Control group without Stabilization Exercises (SE)
Number of subjects: 40
Study 35474569 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis (BL‐11) probiotic supplementation
Number of subjects: 36
Study 34309668 — intervention group
Group type: EXPERIMENTAL
Intervention: Nontargeted screening
Number of subjects: 76561
Study 34309668 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced targeted screening
Number of subjects: 76561
Study 34309668 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional targeted screening
Number of subjects: 76561
Study 34309668 — intervention group
Group type: COMPARATOR
Intervention: Enhanced targeted and traditional targeted combined
Number of subjects: 76561
Study 34309668 — intervention group
Group type: COMPARATOR
Intervention: Enhanced targeted only
Number of subjects: 76561
Study 36282931 — intervention group
Group type: EXPERIMENTAL
Intervention: sotrovimab
Number of subjects: 1057
Study 36282931 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1057
Study 33820449 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (5 sets × 5 repetitions maximum)
Number of subjects: 41
Study 33820449 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity resistance training (2 sets × 25 repetitions maximum)
Number of subjects: 41
Study 34303323 — intervention group
Group type: EXPERIMENTAL
Intervention: Jyoti-Trataka yoga (daily 55-min sessions for one month)
Number of subjects: 60
Study 34303323 — intervention group
Group type: COMPARATOR
Intervention: Control group (administered oral hypoglycemic drugs only)
Number of subjects: 60
Study 34303323 — intervention group
Group type: EXPERIMENTAL
Intervention: Between-group comparison post-treatment
Number of subjects: 60
Study 33091807 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS over left PPC
Number of subjects: 51
Study 33091807 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS over left IFG
Number of subjects: 51
Study 33091807 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 51
Study 35428352 — intervention group
Group type: EXPERIMENTAL
Intervention: COLORS training
Number of subjects: 5000
Study 35428352 — intervention group
Group type: COMPARATOR
Intervention: General online LGBT cultural competency training
Number of subjects: 5000
Study 34479668 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% Chlorhexidine
Number of subjects: 61
Study 34479668 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Povidone-iodine
Number of subjects: 61
Study 34479668 — intervention group
Group type: COMPARATOR
Intervention: Control (distilled water)
Number of subjects: 61
Study 32280080 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine combined with betahistine
Number of subjects: 80
Study 32280080 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (control group)
Number of subjects: 80
Study 35559515 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxia (IH, n=11)
Number of subjects: 17
Study 35559515 — intervention group
Group type: COMPARATOR
Intervention: Intermittent Normoxia (IN, n=6)
Number of subjects: 17
Study 33899246 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame oil (SO)
Number of subjects: 93
Study 33899246 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola oil (CO)
Number of subjects: 93
Study 33899246 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame-canola oil (SCO)
Number of subjects: 93
Study 33332779 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg per kilogram of body weight intravenously)
Number of subjects: 389
Study 33332779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study 33332779 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 389
Study 33075782 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunch intervention
Number of subjects: 17
Study 33075782 — intervention group
Group type: COMPARATOR
Intervention: Dinner intervention
Number of subjects: 17
Study 36085179 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered micro-saw
Number of subjects: 60
Study 36085179 — intervention group
Group type: COMPARATOR
Intervention: Conventional osteotome
Number of subjects: 60
Study 32945218 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1500 mg) plus myoinositol (4 g) per day
Number of subjects: 116
Study 32945218 — intervention group
Group type: COMPARATOR
Intervention: Myoinositol (4 g) per day
Number of subjects: 116
Study 35946404 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiography+FFR
Number of subjects: 1100
Study 35946404 — intervention group
Group type: COMPARATOR
Intervention: Angiography
Number of subjects: 1100
Study 33090016 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast acting insulin aspart (FA)
Number of subjects: 40
Study 33090016 — intervention group
Group type: COMPARATOR
Intervention: Insulin aspart (IAsp)
Number of subjects: 40
Study 32623833 — intervention group
Group type: EXPERIMENTAL
Intervention: Micellar water, cream, and serum
Number of subjects: 60
Study 32623833 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 34928336 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled Higher Doses (PHD) group (≥1 000 IU/day, n = 349)
Number of subjects: 688
Study 34928336 — intervention group
Group type: COMPARATOR
Intervention: Control group (200 IU/day, n = 339)
Number of subjects: 688
Study 34928336 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled Higher Doses (PHD) group (≥1 000 IU/day)
Number of subjects: 688
Study 34928336 — intervention group
Group type: COMPARATOR
Intervention: Control group (200 IU/day)
Number of subjects: 688
Study 33902653 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (CHG) bathing intervention
Number of subjects: 14
Study 33902653 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 14
Study 35497400 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived breast cancer risk
Number of subjects: 339
Study 35497400 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger participants
Number of subjects: 339
Study 35497400 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI utilization
Number of subjects: 339
Study 32708828 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to Mediterranean lifestyle (diet and exercise)
Number of subjects: 6355
Study 32708828 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher desired weight loss (Q4: ≥20%)
Number of subjects: 6355
Study 32730089 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper cervical spine manipulation (C1-C2)
Number of subjects: 186
Study 32730089 — intervention group
Group type: COMPARATOR
Intervention: Combination of cervical (C3-C4), cervicothoracic (C7-T1) and thoracic spine (T5-T6) thrust joint manipulation
Number of subjects: 186
Study 33561663 — intervention group
Group type: EXPERIMENTAL
Intervention: VASobs
Number of subjects: 100
Study 32721948 — intervention group
Group type: EXPERIMENTAL
Intervention: ZNF217 targeting with preexisting therapies, such as the Akt inhibitor triciribine
Number of subjects: 0
Study 32721948 — intervention group
Group type: COMPARATOR
Intervention: High mammographic density
Number of subjects: 0
Study 32721948 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen density and matrix stiffness
Number of subjects: 0
Study 34223683 — intervention group
Group type: EXPERIMENTAL
Intervention: Usability testing of the proposed study method
Number of subjects: 0
Study 32568205 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (n=13; average dose=7.3 mg)
Number of subjects: 33
Study 32568205 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (n=11; average dose=31.8 mg)
Number of subjects: 33
Study 32568205 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicergoline (n=9; average dose=14.5 mg)
Number of subjects: 33
Study 33723687 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal fractional CO2 laser therapy
Number of subjects: 84
Study 33723687 — intervention group
Group type: COMPARATOR
Intervention: Kegel exercise training
Number of subjects: 84
Study 33774639 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of collagen peptides (CP)
Number of subjects: 99
Study 33774639 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of collagen peptides (CP)
Number of subjects: 99
Study 33774639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 34501582 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit resistance training (RT) program, 3 days/week for 12 weeks (n = 18)
Number of subjects: 36
Study 34501582 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 18)
Number of subjects: 36
Study 34501582 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit resistance training (RT) program
Number of subjects: 36
Study 32234463 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 318
Study 32234463 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 318
Study 32998038 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 positive patients
Number of subjects: 1054
Study 33913736 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate tablet (50 mg two times daily) combined with HAART
Number of subjects: 45
Study 33913736 — intervention group
Group type: COMPARATOR
Intervention: HAART alone
Number of subjects: 45
Study 35788775 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary advice to isocalorically increase protein intake to ≥ 1.2 g/kg aBW/d (Protein + ; n = 84)
Number of subjects: 124
Study 35788775 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 40)
Number of subjects: 124
Study 35880828 — intervention group
Group type: EXPERIMENTAL
Intervention: Krill oil (4 g/d; 0.60 g EPA/d, 0.28 g DHA/d, 0.45 g astaxanthin/d)
Number of subjects: 235
Study 35880828 — intervention group
Group type: COMPARATOR
Intervention: Placebo (mixed vegetable oil)
Number of subjects: 235
Study 35263653 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 849
Study 35263653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 849
Study 35263653 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS (Mechanical Circulatory Support)
Number of subjects: 849
Study 35263653 — intervention group
Group type: COMPARATOR
Intervention: No MCS
Number of subjects: 849
Study 33612591 — intervention group
Group type: EXPERIMENTAL
Intervention: High Sugar Diet (HS) - 24% energy from sugar
Number of subjects: 25
Study 33612591 — intervention group
Group type: COMPARATOR
Intervention: Low Sugar Diet (LS) - 6% energy from sugar
Number of subjects: 25
Study 35712946 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular bloodletting combined with auricular point sticking once a week for 4 weeks (treatment group 1)
Number of subjects: 90
Study 35712946 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular bloodletting combined with auricular point sticking twice a week for 4 weeks (treatment group 2)
Number of subjects: 90
Study 35712946 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular bloodletting combined with auricular point sticking three times a week for 4 weeks (treatment group 3)
Number of subjects: 90
Study 35712946 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 90
Study 33749948 — intervention group
Group type: EXPERIMENTAL
Intervention: Kitchen area concentrations of black carbon (BC)
Number of subjects: 180
Study 33749948 — intervention group
Group type: EXPERIMENTAL
Intervention: Kitchen area concentrations of nitrogen dioxide (NO2)
Number of subjects: 180
Study 33749948 — intervention group
Group type: EXPERIMENTAL
Intervention: Kitchen area concentrations of PM2.5
Number of subjects: 180
Study 33749948 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal exposures to pollutants
Number of subjects: 180
Study 32119886 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin conductance level during sequence blocks
Number of subjects: 0
Study 32119886 — intervention group
Group type: EXPERIMENTAL
Intervention: Parietal EEG alpha and gamma power during sequence blocks
Number of subjects: 0
Study 32119886 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral performance (faster responses in sequence than in random blocks)
Number of subjects: 0
Study 32119886 — intervention group
Group type: COMPARATOR
Intervention: EEG parietal gamma power
Number of subjects: 0
Study 35845983 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction
Number of subjects: 98
Study 35845983 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 98
Study 34505832 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowered Relief (ER)
Number of subjects: 104
Study 34505832 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 104
Study 33235314 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel/carboplatin plus cetuximab (group B)
Number of subjects: 150
Study 33235314 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel/carboplatin (group A)
Number of subjects: 150
Study 33228772 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous enteral nutrition
Number of subjects: 0
Study 33228772 — intervention group
Group type: COMPARATOR
Intervention: Intermittent enteral nutrition
Number of subjects: 0
Study 35429820 — intervention group
Group type: EXPERIMENTAL
Intervention: CostCOM (n=32)
Number of subjects: 62
Study 35429820 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=30)
Number of subjects: 62
Study 33054640 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing or sitting postures at work
Number of subjects: 500
Study 33054640 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical examinations (in a subgroup of 100 people)
Number of subjects: 500
Study 35693258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound image-guided surgeries with an optimized image processing algorithm
Number of subjects: 60
Study 35693258 — intervention group
Group type: COMPARATOR
Intervention: X-ray-guided foraminal microscope
Number of subjects: 60
Study 32740716 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care with daily traditional experiential music listening
Number of subjects: 79
Study 32740716 — intervention group
Group type: COMPARATOR
Intervention: Standard care only (Control Group)
Number of subjects: 79
Study 33201130 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression (IPC) in addition to standard prophylaxis with anti-embolic stockings and low-molecular-weight heparin
Number of subjects: 407
Study 33201130 — intervention group
Group type: COMPARATOR
Intervention: Standard prophylaxis alone (control group)
Number of subjects: 407
Study 33201130 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression (IPC)
Number of subjects: 407
Study 36308132 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification cataract surgery
Number of subjects: 310
Study 36308132 — intervention group
Group type: COMPARATOR
Intervention: Manual small-incision cataract surgery (MSICS)
Number of subjects: 310
Study 33970256 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot buprenorphine (weekly or monthly)
Number of subjects: 119
Study 33970256 — intervention group
Group type: COMPARATOR
Intervention: Sublingual buprenorphine (daily)
Number of subjects: 119
Study 32376759 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal fentanyl (NF) and buccal midazolam (BM) administered by family members
Number of subjects: 0
Study 32376759 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal midazolam (BM) alone
Number of subjects: 0
Study 32376759 — intervention group
Group type: COMPARATOR
Intervention: Standard breakthrough medication by nurses
Number of subjects: 0
Study 36460236 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver Modified Atraumatic Restorative Treatment (SMART)
Number of subjects: 67
Study 36460236 — intervention group
Group type: COMPARATOR
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 67
Study 34392656 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir plus Ganshuang granule (GSG)
Number of subjects: 135
Study 34392656 — intervention group
Group type: COMPARATOR
Intervention: Entecavir plus placebo
Number of subjects: 135
Study 32400089 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative bed exercises and mobilization training
Number of subjects: 60
Study 36351436 — intervention group
Group type: EXPERIMENTAL
Intervention: Genicular nerves block (20 ml ropivacaine 0.2%)
Number of subjects: 60
Study 36351436 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration analgesia (150 ml ropivacaine 0.2%)
Number of subjects: 60
Study 33980467 — intervention group
Group type: EXPERIMENTAL
Intervention: Tivozanib
Number of subjects: 0
Study 33980467 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 0
Study 35869721 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpotomy with CEM (205 cases)
Number of subjects: 615
Study 35869721 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpotomy with MTA (207 cases)
Number of subjects: 615
Study 35869721 — intervention group
Group type: COMPARATOR
Intervention: Root canal therapy (RCT) (203 cases)
Number of subjects: 615
Study 32725960 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS (HF-rTMS) during active cycling
Number of subjects: 12
Study 32725960 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 12
Study 32725960 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS (HF-rTMS)
Number of subjects: 12
Study 36109696 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive treatment based on botulinum toxin or oral drugs after 3 months
Number of subjects: 46
Study 36109696 — intervention group
Group type: COMPARATOR
Intervention: Control group (50 subjects)
Number of subjects: 46
Study 32330764 — intervention group
Group type: EXPERIMENTAL
Intervention: VIT-based message (yes)
Number of subjects: 282
Study 32330764 — intervention group
Group type: COMPARATOR
Intervention: Physical harms emphasized (yes)
Number of subjects: 282
Study 35379019 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone Hexacetonide (TH) 40 mg
Number of subjects: 100
Study 35379019 — intervention group
Group type: COMPARATOR
Intervention: Saline Solution (SS)
Number of subjects: 100
Study 35379019 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 100
Study 33401279 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab plus narrow-band UVB (NB-UVB) phototherapy
Number of subjects: 45
Study 33401279 — intervention group
Group type: COMPARATOR
Intervention: Dupilumab alone
Number of subjects: 45
Study 33082492 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle-induced weight loss intervention over 6 months
Number of subjects: 39
Study 33017047 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ketamine
Number of subjects: 22
Study 33017047 — intervention group
Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 22
Study 32176813 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance and impact training (HiRIT)
Number of subjects: 93
Study 32176813 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-based isometric axial compression (IAC)
Number of subjects: 93
Study 32176813 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 93
Study 35276467 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliravira® package plus routine treatments of COVID-19
Number of subjects: 0
Study 35276467 — intervention group
Group type: COMPARATOR
Intervention: Routine treatments of COVID-19 alone
Number of subjects: 0
Study 35241145 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil-propofol combined with dexmedetomidine
Number of subjects: 120
Study 32486877 — intervention group
Group type: COMPARATOR
Intervention: Serum total bilirubin tertile 3 (12.9–34.1 μmol/L)
Number of subjects: 19906
Study 32486877 — intervention group
Group type: COMPARATOR
Intervention: Direct bilirubin tertile 3 (2.5–24.8 μmol/L)
Number of subjects: 19906
Study 33934412 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transfer (FMT)
Number of subjects: 11
Study 35443304 — intervention group
Group type: EXPERIMENTAL
Intervention: School meals (Nutrition Improvement Program)
Number of subjects: 26778
Study 33258355 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese exercises combined with traditional Chinese massage
Number of subjects: 70
Study 33258355 — intervention group
Group type: COMPARATOR
Intervention: Traditional Chinese exercises
Number of subjects: 70
Study 34047839 — intervention group
Group type: EXPERIMENTAL
Intervention: VITOM 3D exoscope
Number of subjects: 71
Study 34047839 — intervention group
Group type: COMPARATOR
Intervention: Operating microscope
Number of subjects: 71
Study 33555697 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure treatment (10 to 15 sessions)
Number of subjects: 43